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Objective. Articular cartilage is incapable of effective repair following injury or during osteoarthritis. 39 
While there have been developments in cartilage repair technologies, there is a need to advance 40 
biologically-relevant models for pre-clinical testing of biomaterial and regenerative therapies. This 41 
study describes conditions for the effective ex vivo culture of the whole human femoral head. 42 
Design. Fresh, viable femoral heads were obtained from femoral neck fractures and cultured for up 43 
to 10wks in: (a) Dulbecco’s modified Eagle’s medium (DMEM); (b) DMEM+mixing; (c) DMEM+10% 44 
human serum (HS); (d) DMEM+10%HS+mixing. The viability, morphology, volume and density of 45 
fluorescently-labelled in situ chondrocytes and cartilage surface roughness were assessed by 46 
confocal microscopy. Cartilage histology was studied for glycosaminoglycan content using Alcian 47 
blue and collagen content using picrosirius red.   48 
Results. Chondrocyte viability remained at >95% in DMEM+10%HS. In DMEM alone, viability 49 
remained high for ~4wks then declined. For the other conditions, superficial zone chondrocyte 50 
viability fell to <35% at 10wks with deeper zones being relatively unaffected. In DMEM+10% HS at 51 
10wks, the number of chondrocytes possessing cytoplasmic processes increased compared to 52 
DMEM (p=0.017). Alcian blue labelling decreased (p=0.02) and cartilage thinned (p≤0.05),  53 
however there was no change to surface roughness, chondrocyte density, chondrocyte volume, or 54 
picrosirius red labelling (p>0.05).  55 
Conclusions. In this ex vivo model, chondrocyte viability was maintained in human femoral heads 56 
for up to 10wks in culture, a novel finding not previously reported. This human model could prove 57 
invaluable for the exploration, development and assessment of pre-clinical cartilage repair and 58 
regenerative therapies.  59 




Articular cartilage has very poor regenerative potential following injury and the repair tissue 62 
formed is mechanically weak, and has a fibro-cartilageneous, rather that the resilient load-bearing 63 
extracellular matrix (ECM) of hyaline cartilage1. Furthermore, the native regeneration potential of 64 
cartilage declines with age2 and while fibro-cartilaginous repair can be observed to form within injured 65 
hyaline cartilage, it is more evident when the injury has penetrated the sub-chondral bone.1,3 The 66 
reasons for the production of mechanically-incompetent repair tissue are not well understood, and 67 
clearly there is intense interest in developing more effective biomaterial and regenerative therapies 68 
for cartilage repair. However, current models are not optimal and usually involve preparations 69 
ranging from in vitro cultures of cells, through to osteochondral explants4 and ex vivo and in vivo 70 
models of mainly animal (i.e. non-human) joints5,6. The research and development of more effective 71 
cartilage repair and regenerative therapies would be enhanced by the ability to pre-clinically evaluate 72 
novel strategies in ex vivo physiological, tribological models of natural joints.   73 
While there have been many detailed studies on explant and organ culture of animal 74 
osteochondral tissue (e.g.7), few studies have conducted experiments directly on human tissue. The 75 
limited studies using human cartilage for experimentation have obtained the material as discarded, 76 
and frequently degenerate osteochondral tissue (e.g. during joint replacement surgery for 77 
osteoarthritis)8. To test orthobiological treatments for human cartilage repair, the use of healthy 78 
cartilage is essential. However, this source of material is difficult to obtain and relies on collaboration 79 
between clinicians, theatre staff and research scientists. Whilst normal human cartilage may be 80 
obtained from amputations, trauma victims or occasionally cadavers, such material is rarely available 81 
for wider adoption into experimental human cartilage research. Ex vivo organ culture is becoming 82 
increasingly important for basic and applied biomedical research because it is more representative 83 
of normal cellular behaviour. However, obtaining a steady supply of viable human tissue which then 84 
has to be cultured for weeks under aseptic conditions remains a challenging research area. 85 
 Femoral neck fractures are one of the most common surgically treated injuries in elderly 86 
patients. The human femoral head is discarded during the surgery undertaken to treat femoral neck 87 
fractures and is replaced with an artificial prosthesis. While this discarded femoral head is aged, it is 88 
generally non-degenerate. We hypothesised that the human femoral head would be a viable source 89 
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of normal, non-degenerate articular cartilage suitable for pre-clinical cartilage research and 90 
regenerative therapies. We were able to coordinate the timely, sterile collection and delivery of the 91 
discarded human femoral head from the operating theatre to the laboratory. The aim of this study 92 
was to optimise the culture conditions for fresh human femoral heads from femoral neck fractures to 93 





Human femoral heads 97 
Femoral heads were obtained with ethical permission (Tissue Governance, National Health 98 
Service, Lothian) and patient consent from 15 patients (11 females, 4 males, mean age 75.5 (range 99 
56-88)) undergoing hemi-arthroplasty or total hip replacement for femoral neck fracture (FNF). 100 
Femoral heads were carefully removed intra-operatively by a qualified orthopaedic surgeon using a 101 
corkscrew device and immediately placed into a sterile container with saline (0.9% w/v;21oC) to 102 
prevent chondrocyte death from drying9.  Femoral heads were then transferred to a sterile container 103 
with Dulbecco’s Modified Eagle’s Medium (DMEM) with D-glucose (25mM), L-Glutamine (4mM), 104 
pyruvate (1mM), 100U/ml penicillin, 100µg/ml streptomycin, 2.5mg/ml amphotericin B (Sigma-105 
Aldrich, Irvine, UK) and 10µg/ml Fungin (InvivoGen, Toulouse, France) ready for transportation to 106 
the laboratory with the femoral heads being available for experiments within 1-2hrs. 107 
 108 
Culture conditions  109 
Femoral heads were maintained in culture (37oC) in sealed single use sterile containers and 110 
media changed every 3 days and the container replaced with every media change. Media volume 111 
for each femoral head was ~50-60ml. Male femoral heads were larger than those of females (diam. 112 
typically 6cm vs 4.5cm) and required larger culture containers. The femoral heads were cultured for 113 
up to 10 weeks under the following conditions: (a) static culture in Dulbecco’s modified Eagle’s 114 
medium (DMEM),  (b) culture in DMEM with movement (DMEM+mixing), (c) as for (a) above +10% 115 
normal human serum (HS, Merck, Feltham, U.K) and (d) as for (b) above +10% HS.  A cavity was 116 
carved in the cancellous bone of the femoral head for a magnetic stirring bar using bone trimmers 117 
(Fig. 1). Containers were then placed on a magnetic mixer inside the incubator and stirring was 118 
programmed for 1h, twice daily at ~1Hz. The rationale for studying the effects of movement was 119 
based on our proof of concept bovine model where joint movement promoted chondrocyte viability7. 120 
 121 
Cartilage sampling, fluorescent labelling of in situ chondrocytes and confocal microscopy 122 
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Full depth cartilage explants were harvested using 3 or 5mm diam. biopsy punches (Kai 123 
Medical, Solingen, Germany) for weekly chondrocyte viability measurements. To minimise the 124 
variability, explants were taken from random areas within the load-bearing parafoveal superior 125 
region10 (Fig. 2). Cartilage samples were then incubated (1.5h;21°C) with CMFDA (5-126 
chloromethylfluorescein diacetate) cell tracker green and PI propidium iodide (12.5 and 10µM, 127 
respectively; Invitrogen, Paisley, U.K.) to label living (green) and dead (red) cells respectively11. 128 
Explants were washed in phosphate-buffered saline (PBS; Invitrogen, Paisley, U.K.), fixed 129 
(formaldehyde 4%v/v;30mins; Fisher, Leicestershire, U.K.) and imaged in three-dimensions by 130 
confocal laser scanning microscopy (CLSM) using established methods12.  131 
 132 
Measurements of chondrocyte viability, density, volume and morphology 133 
Confocal projected axial views were analysed using ImageJ/FIJI (National Institutes of 134 
Health) and IMARIS software (Zurich, Switzerland) as described12. Chondrocyte viability (% live 135 
cells) was calculated as: the number of CMFDA-labelled cells/(number of CMFDA-labelled cells + 136 
number of PI-labelled cells) in a given Region of Interest (ROI) volume. For chondrocyte density, the 137 
total number of cells (CMFDA-labelled and PI-labelled) in the ROI volume were counted in IMARIS, 138 
and results given as cells/μm3. Chondrocyte volumes were obtained using the IMARIS ‘Surfaces’ 139 
algorithm. Volume calibration was performed using fluorescent microspheres (Polysciences, 140 
Warrington, USA). Chondrocyte morphology was considered ‘normal’ if cells were visualised as 141 
having a ‘smooth’ surface and elliptical/rounded shape. ‘Abnormal’ chondrocytes exhibited at least 142 
one CMFDA-labelled cytoplasmic process ≥2μm long. Abnormal cells were counted manually and 143 
divided by the total number of live cells in the field of view with results presented as the % abnormal 144 
cells in the whole cell population within the ROI12.   145 
 146 
Histology, cartilage thickness and surface roughness 147 
Explants were frozen (-80oC) in a freezing medium (1:1 Optimal temperature cutting 148 
compound with 30% w/v sucrose in PBS for histology13,14. The plugs were then cut into 40µm 149 
sections and stained with Alcian blue (Vector Laboratories Ltd., Peterborough, U.K.) to label cartilage 150 
glycosaminoglycans according to manufacturer’s instructions. For picrosirius red staining of 151 
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collagens, sections of 10µm thickness were first stained with haematoxylin for 8mins, then washed 152 
3-4x in distilled water. This was followed by 1h incubation in 0.1% picrosirius red (Direct Red 80, 153 
Sigma-Aldrich, Irvine, U.K.) in picric acid (VWR International, Lutterworth, U.K.). Sections were 154 
washed briefly 2x in 0.5% acetic acid, dehydrated (two washes in ethanol absolute followed by one 155 
wash in xylene) and mounted in resinous mounting medium. Histological sections were imaged on 156 
a Leica bright field microscope and analysed with ImageJ/FIJI software15. After converting the 157 
images to greyscale 8-bit pixel depth, the same intensity threshold was set for each pair of sections 158 
(week 0 vs week 10). The stained area above the threshold was measured and presented as a % of 159 
the total sectional area. Cartilage thickness measurements were performed on the coronal sections 160 
of cartilage using ImageJ/FIJI. For the surface roughness measurements, the ImageJ/FIJI Analyse 161 
Stripes macro was used on the images of histologically-stained sections.  Calculation of cartilage 162 
surface roughness was based on the deviation from an idealized smooth cartilage surface, and 163 
expressed as Rq (the root mean square (RMS) deviation) in µm.  164 
 165 
Data presentation and statistical analysis 166 
Statistical analyses were performed using Graphpad Prism ver.8.2.1 (GraphPad Software, 167 
La Jolla, U.S.A.). Data were presented as (N(n)), with (N) representing the number of independent 168 
femoral heads and (n) the total number of replicates. Each data point presented on graphs and used 169 
for statistical analyses was an average (± S.D. or S.E.M. as indicated) of the replicates taken from 170 
each femoral head. Unless otherwise stated, paired Student’s t-tests were used to compare 171 
differences within pairs of treatment groups or time points, and ANOVA used to compare differences 172 





Cartilage grading and chondrocyte viability 176 
Femoral heads were macroscopically assessed using an established system16. For all 177 
femoral heads considered suitable, the cartilage was grade 0 over >75% of the surface, with small 178 
isolated grade 1 lesions in the parafoveal area (which were <25% of the surface area). The isolated 179 
areas of grade 1 cartilage (mild surface fibrillation) were not studied and only cartilage of grade 0 180 
was used.  181 
Chondrocyte viability was assessed on day 1 and any femoral heads with a viability of <80% 182 
were excluded. Out of a total of 24 femoral heads received, five were excluded due to low initial 183 
chondrocyte viability and a further four were also excluded as they developed infection during 184 
subsequent culture. In the remaining 15 femoral heads, the cell viability was 95.3±5.3% 185 
(N(n)=15(60)) on Day 1. Chondrocyte viability in femoral heads cultured under static conditions in 186 
DMEM remained high (>90%) for ~4wks but decreased to 44.0±22.3% by week 10 (N(n)=4(16), one-187 
way ANOVA, post-test for trend, p=0.045, Fig. 3A). This decrease in cell viability was accelerated 188 
with movement of the femoral head and stirring of the media with virtually no viable cells by week 6 189 
(two-way ANOVA;p=0.0099, Fig. 3A). The addition of 10% HS to DMEM maintained chondrocyte 190 
viability at >90% to week 10 under static femoral head culture conditions (Fig. 3B) but did not 191 
significantly improve the viability in femoral head cultures with movement/stirring over 10 weeks. 192 
CLSM permits three-dimensional imaging and quantitative analyses of chondrocyte viability 193 
within the full depth of cartilage17. To assess if chondrocytes within any zone were more sensitive 194 
during culture, chondrocyte viability was determined as a function of depth from the articular surface. 195 
We compared the percentage cell viability within the different zones (SZ, MZ, DZ) in coronal sections 196 
of articular cartilage at week 10 compared with baseline (week 0). There was a decrease in the SZ 197 
viability in both culture conditions (DMEM only, and DMEM+mixing; (p=0.0425 and p=0.016 198 
respectively; Fig. 4A)) with relative preservation of cell viability in deeper cartilage zones (Fig. 4B). 199 
This suggest that SZ chondrocytes were far more sensitive to the culture conditions compared to the 200 
cells in the deeper zones. Thus, although there were few living SZ cells remaining after 10wks, a 201 




Chondrocyte morphology 204 
In fresh explants of macroscopically non-degenerate femoral head cartilage, a small 205 
population (8.0±1.5% (N(n)=4(8)) of cells in the SZ (~100µm from the surface) demonstrated one or 206 
more cytoplasmic processes (Fig 5. A,B). During femoral head culture in DMEM, there appeared to 207 
be an increase in the % of cells with processes (to 15±5.3% by week 6, N(n)=4(16)) and (16±6.4% 208 
by week 10 N(n)=4(16)) however these changes were not significantly different compared to week 209 
0 (ANOVA;p>0.05). In contrast, in the presence of HS, the % of chondrocytes with processes 210 
increased to 31±9.3% by week 6 (p=0.008;N(n)=3(12)) and 37±7.1% by week 10 211 
(p=0.002;N(n)=3(12)) compared to week 0 (Fig. 5B). By week 10, there were significantly more (by 212 
>2-fold;p=0.017) chondrocytes with cytoplasmic processes when femoral heads were cultured in 213 
DMEM+HS compared to DMEM alone (Fig. 5B).  214 
 215 
Extracellular matrix composition 216 
To evaluate whether extracellular matrix composition changed during culture, two histological 217 
stainings were performed on cartilage samples (week 0 and week 10) and analysed semi-218 
quantitatively. There was a general trend of decreasing GAG staining using Alcian blue18 under all 219 
culture conditions, but in DMEM+HS chondrocyte viability was significantly higher (Fig. 6A). In these 220 
cultures 50.0±2.86% (N(n)=3(6)) of the section area was stained with Alcian blue at week 0. This 221 
decreased to 17.0±13.8% by week 10 (N(n)=3(6);p=0.028)). The total collagen stained with 222 
picrosirius red did not show any significant difference between DMEM and DMEM+HS samples at 223 
week 0 and week 10 (30±5% vs 42±22%, N(n)=11(22);p=0.09). These results suggest a significant 224 
loss of GAGs but no change to the total collagen content of femoral head cartilage during this culture 225 
period.  226 
 227 
Cartilage thickness and surface roughness 228 
In parallel with the loss of GAGs, cartilage thickness was reduced after 10wks in culture (Fig. 229 
6B). In DMEM cultures, it decreased from 3808±425µm to 2828±542µm (p=0.05;N(n)=4(22)). In the 230 
DMEM+mixing culture it declined from 4226±418µm to 2703±720µm (p=0.02;N(n)=4(15)), and in 231 
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DMEM+10% human serum it decreased from 3377±360µm to 2349±160µm (p=0.02;N(n)=3(22)). 232 
Articular surface roughness assessed on the same femoral heads at week 0 and week 10 was not 233 
significantly different (13±0.6µm and 15±0.7µm respectively (p=0.55;N(n)=9(9);Fig. 7A)). 234 
  235 
Chondrocyte density and volume  236 
There was no difference in cell density for all the samples at week 0 (9971±2389 cells/mm3 237 
N(n)=15(60)) compared with week 10 (11256±3305 cells/mm3 (p=0.01;N(n)=15(60));Fig 7B)). In situ 238 
chondrocyte volume was also analysed as it correlates with the progression of cartilage 239 
degeneration, however, there was no difference (p=0.22) between the cell volumes of chondrocytes 240 
on day 0 (423±49µm3, N(n)=15(60) and week 10 (441±48µm3, N(n)=15(60);Fig. 7C).  241 
 242 





We have established culture conditions which maintain chondrocyte viability during ex vivo 246 
culture of human femoral heads for 10 weeks by supplementing standard culture medium with 10% 247 
normal human serum. We have identified an excellent and reliable source of viable, non-degenerate 248 
human articular cartilage ideal for ex vivo experimentation. Previously, we have investigated the 249 
microscopic effects of mechanical and other forms of injury on human articular cartilage9,19. However 250 
material was obtained from tissue discarded during knee replacement for osteoarthritis and the yield 251 
of non-degenerate tissue was often low. This was because the majority of the tissue was 252 
osteoarthritic with loss of superficial zone cells, even if macroscopically the tissue may have 253 
appeared non-degenerate. In contrast, the cartilage of the femoral head discarded after femoral neck 254 
fracture was in most cases non-degenerate and our experiments have confirmed the presence of 255 
viable cartilage tissue that is macroscopically and microscopically ideally suited for investigating 256 
cartilage repair and regeneration. Due to the excellent chondrocyte viability throughout culture, the 257 
model may also allow ex vivo validation of an optimal combination of cells, growth factors and 258 
scaffolds that lead to the formation of repair tissue resembling the desirable hyaline articular cartilage 259 
at the microscopic level. 260 
Current knowledge of the microscopic quality of cartilage repair tissue in humans is based 261 
on histological assessment of opportunistic biopsy specimens retrieved during 'second look’ 262 
arthroscopy (keyhole surgery). While these specimens have provided valuable insight into the quality 263 
of cartilage repair, with so called ‘hyaline-like’ composition, the information is limited by small 264 
numbers of specimens, distortion of the tissue during biopsy, variability in the site/size of biopsies 265 
and heterogeneity of the study sample. The lack of a non-invasive method of evaluating the 266 
microscopic characteristics of the quality of the cartilage repair tissue has also been recognized as 267 
a major problem limiting advances in cartilage repair and regenerative techniques by the 268 
International Cartilage Repair Society (ICRS)20. Modern imaging techniques (e.g. CLSM) allow 269 
microscopic examination of articular cartilage by optically sectioning the tissue. We believe that the 270 
significantly easier access to normal, human cartilage ex vivo will help overcome the problems 271 
associated with in vivo biopsy, and allow detailed quantitative microscopic assessment and 272 
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optimisation of the quality of cartilage repair. The proposed model will significantly enhance our 273 
ability to test a wide range of pre-clinical therapeutic cartilage repair and regenerative strategies 274 
directly in human tissue so that the best candidate therapies can be identified for subsequent clinical 275 
study. 276 
In our model, the large area of grade 0 cartilage (Fig. 1) permitted multiple samples to be 277 
taken either at a single time point, or a smaller number over a longer time course. A gap between 278 
samples was retained so that cutting trauma using the biopsy punch21 did not influence neighbouring 279 
samples. Furthermore, if cartilage wells were to contain biological models for testing, then it would 280 
be possible for the full depth sample to be ‘scooped’ out using a fine scalpel blade. Chondrocyte 281 
viability in both axial and coronal projections was initially high for all samples (Fig. 3A). There was 282 
no change in viability during DMEM+HS culture, suggesting that taking multiple cartilage plugs over 283 
the 10wk period did not adversely affect the viability of the surrounding cartilage. It should be noted 284 
that if serum (HS) was used, then it must be heat-treated because it contains enzymes that digest 285 
the DNA of dead cells leading to an under-estimation of the dead cell population22,23.  286 
Femoral head culture in DMEM maintained chondrocyte viability for ~4wks after which there 287 
was an increase in chondrocyte death (Fig. 3A). With mixing, viability decreased progressively after 288 
the start of the culture, such that by week 10 there were virtually no remaining viable cells. 289 
Furthermore, cell death started in the SZ so that after 10wks, all these chondrocytes were dead 290 
whereas those in the deeper zones were still viable (Fig. 4). This suggests that there are factors in 291 
bone supporting chondrocyte viability in the superficial zone which were washed out during media 292 
changes. The importance of bone in cultures of bovine cartilage has been reported previously as SZ 293 
chondrocyte viability was maintained in cartilage cultures when bone was present either when 294 
attached to the explants or in co-culture24. This was in contrast to deep zone chondrocytes which 295 
survived, and the relative viability of these chondrocytes within the femoral head cartilage of our 296 
elderly patients (Fig. 4) parallels the long-term (~25yr) survival of DZ chondrocytes in osteochondral 297 
allografts used for the treatment of focal post-traumatic defects in young individuals25. It is possible 298 
that these chondrocytes are well adapted to this relatively hostile environment for example 299 
chondrocytes in the DZ utilise different membrane transport systems for the regulation of intracellular 300 
acidity compared to cells in the SZ26. The addition of HS in the mixed DMEM condition provided 301 
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some protection for SZ chondrocytes as cell viability by week 10 was 35% (Fig. 3B). However, if 302 
there was no mixing and HS was present, there was complete chondrocyte protection suggesting 303 
that serum was protecting the cells which were vulnerable during the latter stages of the culture. 304 
While the cross-talk between subchondral bone and cartilage has received considerable attention27 305 
the factor(s) released from bone and/or present in the serum which promote chondrocyte viability 306 
are unclear, with TGFβ, IGF-1 and BMP being implicated28. 307 
Visualisation of fluorescently-labelled in situ chondrocytes revealed the classical morphology 308 
of elliptical cells in the SZ with the more spheroidal forms in the deeper zones (Fig. 4)12. In grade 0 309 
cartilage in axial projections, a small proportion (~8%) of the SZ cells (within ~100µm depth). 310 
exhibited cytoplasmic processes. Of interest was that after 10wks of culture in DMEM+HS, there 311 
was a significant (>4-fold) increase in the % of cells exhibiting processes (Fig. 5A). At week 10, 312 
significantly (by >2-fold) more chondrocytes demonstrated a cytoplasmic process when HS was 313 
present compared to culture in DMEM alone. However, in the DMEM+HS condition, chondrocyte 314 
viability and density did not change during culture (Figs. 3B & 7B respectively), whereas in DMEM 315 
alone viability had decreased by ~50% (Fig. 3A) but abnormal chondrocytes were still present (Fig. 316 
5B). The changes to chondrocyte shape might be related to the properties of the ECM. In healthy 317 
cartilage, the pore size of the PG network is ~3nm whereas that for collagen is ~100nm and thus the 318 
PGs will regulate cartilage permeability and solute diffusivity29. GAG loss during unloading will 319 
increase matrix permeability and thus potent growth factors etc., in serum will start to penetrate and 320 
act particularly on SZ chondrocytes which are normally shielded by the tight matrix. The development 321 
of processes and subsequent abnormal morphology of chondrocytes is a feature associated with de-322 
differentiation to a fibroblastic phenotype30,31 and has been observed in osteoarthritic tibial and 323 
femoral head cartilage17,32,33. A change in phenotype is characterised by decreased hyaline cartilage-324 
specific collagen type II and aggrecan production, and an increase in collagen type I production. It 325 
would be of particular interest to determine if physiological levels of loading could reverse some of 326 
these changes and protect the chondrocyte phenotype and promote the production of a hyaline 327 
cartilage17.  328 
There was no evidence of chondrocyte clustering34 under any of the experimental conditions. 329 
Nomura et al.35 did not observe changes to chondrocyte morphology in mice subjected to hindlimb 330 
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unloading when cartilage was studied by histology. This might appear to conflict with the changes to 331 
chondrocyte morphology reported here. However the detection of the fine cytoplasmic process is not 332 
possible with their histological techniques as they involve tissue shrinkage36 and high resolution 333 
imaging of unperturbed in situ chondrocyes is essential for the visualisation of the processes17,31. 334 
It might be considered that a limitation in our study was that no mechanical load was applied 335 
to the femoral heads. However this revealed that after 10wks there were features of the cartilage 336 
ECM and in situ chondrocytes which bear similarities to the changes observed with both in vivo and 337 
in vitro cartilage disuse atrophy. Alcian blue staining reflecting GAG content was decreased (Fig. 338 
6A,C). This was not significant in the DMEM and DMEM+mixing conditions when there was 339 
substantial chondrocyte death (~50% and 100% respectivey). However, interestingly, the decrease 340 
was significant in the DMEM+HS condition (Fig.6A) when cell viability was high (>95%). This 341 
suggests that there was an active chondrocyte-driven process mediating reduced GAG levels37. 342 
GAG loss would probably account for the cartilage thinning (Fig. 6B), reported by others using animal 343 
joint immobilisation models35. GAG loss did not however, affect surface roughness (Fig. 7A) which 344 
is in contrast to the changes occurring in OA, where GAG levels decrease and surface roughness 345 
and cartilage fibrillation increase28. Palmoski et al.38 noted a similar decrease in PG staining in 346 
healthy adult dogs after ~6 days of immobilisation and by 8wks there was a 30-50% reduction in 347 
cartilage thickness with an almost complete loss of PG. In human joints immobilised as a result of 348 
ankle fracture, there was a 6.6% loss of cartilage thickness over 7wks following fracture39. The loss 349 
of GAGs is thought to be due to a reduction in synthesis as well as the stimulation of chondrocyte 350 
degradative enzyme (MMP-13, ADAMTS5) activity35,37 from a mechano-adaptive response to 351 
reduced load. Mechanical loading of joints is a key parameter for maintaining the differentiated, 352 
rounded, chondrocyte phenotype40,41. Recent studies implicate an essential role for the 353 
mechanosensitive ion channel Transient Receptor Potential Vanilloid 4 (TRPV4) in the signal 354 
transduction pathway. Inhibiting TRPV4 prevents loading-mediated increases in matrix synthesis, 355 
whereas activating TRPV4 in the absence of loading increases matrix synthesis in a manner 356 
analogous to loading42.  357 
While there were changes to GAG labelling, there was no change to picrosirius red labelling 358 
suggesting the cartilage collagen content remained unaltered throughout culture. While picrosirius 359 
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red does not discriminate between the collagen types43 it is possible that there were changes to 360 
collagen metabolism and/or its organisation. For example, while total collagen content might not 361 
have change significantly, it is possible that there was a decrease in the collagen type II : type I ratio 362 
reflecting chondrocyte de-differentiation. In addition, changes to collagen fibre distribution/orientation 363 
could be evident, and future studies utilising polarized light microscopy would be worth pursuing. A 364 
small decrease in collagen cross-linking which recovers after re-mobilisation has been reported44 365 
and the immobilisation of rabbit knee joint leads to a partial shift in the density of collagen 366 
composition from type II to type I45. However, in human cartilage, there is negligible/minimal collagen 367 
turnover over the lifetime in a healthy joint46. 368 
There was no change to the volume of in situ chondrocytes following 10wks culture in 369 
DMEM+HS (Fig. 7C). It is likely that with the loss of GAGs, interstitial osmolarity of the matrix would 370 
decrease, leading to hypo-osmolarity and cell swelling. However in situ chondrocytes possess 371 
effective volume-regulatory channels and transporters47,48 and over a long time period, despite the 372 
change in osmolarity, these mechanisms could compensate leading to no volume change. This 373 
phenomenon (termed iso-volumetric volume regulation (IVR)) has been described in various cell 374 
types including chondrocytes49. The lack of chondrocyte swelling is in contrast to that observed in 375 
osteoarthritic cartilage where increased chondrocyte volume/hypertrophy has been reported17,50. 376 
This study described the first successful ex vivo culture of a large human joint. In situ 377 
chondrocyte viability remained high in DMEM+HS, however it decreased under the other conditions 378 
tested. Although chondrocyte viability was optimal, there were changes to the matrix (cartilage 379 
thinning, GAG loss, no change to collagen or surface roughness) and chondrocytes (development 380 
of cytoplasmic processes, no change to volume or density). This pre-clinical model may be an 381 
invaluable addition for the assessment of human cartilage repair therapies and may replace some 382 
animal studies.  383 
 384 
Acknowledgements. 385 
We thank Ms F. Stewart for excellent assistance with the provision of the femoral heads, Dr 386 
A. Kubasik-Thayil at the IMPACT imaging facility in the Centre for expert assistance with confocal 387 




Role of the Funding Source. 390 
This work was supported by a project grant from the Chief Scientist’s Office (Scotland) 391 
TCS/18/01. 392 
 393 
Author Contributions. 394 
Study concept and design; Amin, Simpson, Hall. Acquisition of data; Styczynska-Soczka. 395 
Analysis and interpretation of data; Styczynska-Soczka, Amin, Simpson, Hall. Manuscript 396 
preparation; Styczynska-Soczka, Amin, Simpson, Hall. 397 
 398 
Conflict of Interest. 399 
 400 





1. Hunziker EB, Lippuner K, Keel MBJ, Shintani N. An educational review of cartilage repair: 404 
precepts & practice - myths & misconceptions - progress & prospects. Osteoarthritis and Cartilage 405 
2015;23:334-350 http://dx.doi.org/10.1016/j.joca.2014.12.011 406 
 407 
2. Brittberg M, Gomoll AH, Canseco JA, Far J, Lind M, Hui J. Cartilage repair in the degenerative 408 
ageing knee. Acta Orthopaedica 2016;87:sup363, 26-38, DOI: 10.1080/17453674.2016.1265877 409 
 410 
3. Simon TM, Aberman HM. Cartilage regeneration and repair testing in a surrogate large animal 411 
model. Tissue Eng Part B Rev 2010;16:65-79. DOI: 10.1089/ten.TEB.2009.0304. 412 
 413 
4. Maglio M, Tschon M, Sicuro L, Lolli R, Fini M. Osteochondral tissue cultures: between limits and 414 
sparks, the next step for advanced in vitro models. J Cell Physiol 2018;234:5420-5435. DOI: 415 
10.1002/jcp.27457 416 
 417 
5. Elson KM, Fox N, Tipper JL, Kirkham J, Hall RM, Fisher J, et al, Non-destructive monitoring of 418 
viability in an ex vivo organ culture model of osteochondral tissue. Europ Cells Mat 2015;29:356-419 
369. DOI: 10.22203/eCM.v029a27 420 
 421 
6. Cope PJ, Ourradi K, Li Y, Sharif M. Models of osteoarthritis: the good, the bad and the 422 
promising. Osteoarthritis and Cartilage 2019;27:230-239. 423 
https://doi.org/10.1016/j.joca.2018.09.016 424 
 425 
7. Lin Y-C, Hall AC, Simpson AHRW. A novel joint organ culture model for evaluation of static and 426 





8. Geurts J, Juric D, Müller M, Schären S, Netzer C. Novel ex vivo human osteochondral explant 430 
model of knee and spine osteoarthritis enables assessment of inflammatory and drug treatment 431 
responses. Int J Mol Sci 2018;19:1314. DOI: 10.3390/ijms19051314 432 
 433 
9. Paterson SI, Amin AK, Hall AC. Airflow accelerates bovine and human articular cartilage drying 434 
and chondrocyte death. Osteoarthritis and Cartilage 2015;23:257-265. DOI: 435 
10.1016/j.joca.2014.10.004. 436 
 437 
10. Greenwald AS, Haynes DW. Weight-bearing areas in the human hip joint. J Bone Jt Surg (Br). 438 
1972;54(1):157-63.  439 
 440 
11. Amin AK, Bush PG, Huntley JS, Simpson AHW, Hall AC. Osmolarity influences chondrocyte 441 
death in wounded articular cartilage. J Bone Jt Surg (Amer) 2008;90:1531-1542. DOI: 442 
10.2106/JBJS.G.00857 443 
 444 
12. Karim A, Amin AK, Hall AC. The clustering and morphology of chondrocytes in normal and 445 
mildly-degenerate human femoral head cartilage studied by confocal laser scanning microscopy. J 446 
Anatomy 2018;232(4):686-698. DOI: 10.1111/joa.12768. 447 
 448 
13. Hyllested JL, Veje K, Ostergaard K. Histochemical studies of the extracellular matrix of human 449 
articular cartilage - A review. Osteoarthritis and Cartilage 2002;10:333–343. 450 
https://doi.org/10.1053/joca.2002.0519  451 
 452 
14. Schmitz N, Laverty S, Kraus VB, Aigner T. Basic methods in histopathology of joint tissues. 453 
Osteoarthritis Cartilage 2010;18:S113-S116. https://doi.org/10.1016/j.joca.2010.05.026  454 
 455 
15. Crowe AR, Yue W. Semi-quantitative determination of protein expression using 456 
immunohistochemistry staining and analysis: An integrated protocol. Bio Protoc 2019;9(24) pii: 457 




16. Pritzker KPH, Gay S, Jimenez SA, Ostergaard K, Peletier J–P, Revell PA, et al (2006). 460 
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis and Cartilage 461 
2006;13:13-29. DOI:10.1016/j.joca.2005.07.014 462 
 463 
17. Bush PG, Hall AC. The volume and morphology of chondrocytes within non-degenerate and 464 
degenerate human articular cartilage. Osteoarthritis and Cartilage 2003;11(4):242-251. 465 
DOI:10.1016/s1063-4584(02)00369-2 466 
 467 
18. Fisher M, Solursh M. Glycosaminoglycan localisation and role in maintenance of tissue spaces 468 
in the early chick embryo. J Embryol Exp Morphol 1977;42:195-207. 469 
 470 
19. Amin AK, Huntley JS, Patton JT, Brenkel IJ, Simpson AHRW, Hall AC. Hyperosmolarity 471 
protects chondrocytes from mechanical injury in human articular cartilage. J Bone Joint Surg [Br] 472 
2011;93-B:277-84. Doi: 10.1302/0301-620X.93B2.24977. 473 
 474 
20. Hoemann C, Kandel R, Roberts S, Saris DB, Creemers L, Mainil-Varlet P et al. International 475 
Cartilage Repair Society (ICRS) Recommended Guidelines for Histological Endpoints for Cartilage 476 
Repair Studies in Animal Models and Clinical Trials. Cartilage 2011;2(2);153-72. 477 
Doi:10.1177/1947603510397535.  478 
 479 
21. Huntley JS, McBirnie JM, Simpson AH, Hall AC. Cutting-edge design to improve cell viability in 480 
osteochondral grafts. Osteoarthritis and Cartilage 2005;13:665-671. DOI: 481 
10.1016/j.joca.2005.04.007 482 
 483 
22. Zhou S, Cui Z, Urban JPG. Dead cell counts during serum cultivation are under-estimated by 484 




23. Karim A, Hall AC. Hyperosmolarity normalizes serum-induced changes to chondrocyte 487 
properties in a model of cartilage injury. Europ Cells Mat 2016;31:205-220. DOI: 488 
10.22203/ecm.v031a14 489 
 490 
24. Amin AK, Huntley JS, Simpson AHW, Hall AC. Chondrocyte survival in articular cartilage:  the 491 
influence of subchondral bone in a bovine model. J Bone Jt Surg (Br) 2009;91-B:691-699. DOI: 492 
10.1302/0301-620X.91B5.21544 493 
 494 
25. Gross AE, Kim W, Las Heras F, Backstein D, Safir O, Pritzker KP. Fresh osteochondral 495 
allografts for posttraumatic knee defects: long-term followup. Clin Orthop Relat Res 496 
2008;466(8):1863-70. DOI: 10.1007/s11999-008-0282-8.  497 
 498 
26. Simpkin VL, Murray DH, Hall AP, Hall AC.  Bicarbonate-dependent pHi regulation by 499 
chondrocytes within the superficial zone of bovine articular cartilage. J Cell Physiol 2007;212(3), 500 
600-609. DOI: 10.1002/jcp.21054 501 
 502 
27. Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, 503 
function and cartilage-bone crosstalk. Nat Rev Rheumatol 2016;12(11):632-644.  504 
DOI: 10.1038/nrrheum.2016.148.  505 
 506 
28. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: A disease of the joint as 507 
an organ. Arth Rheum 2012;64(6):1697–1707. DOI:10.1002/art.34453 508 
 509 
29. Graham BT, Wright AD, Burris DL, Axe MJ, Raisis LW, Price C. Quantification of solute 510 
diffusivity in osteoarthritic human femoral head cartilage using correlation spectroscopy. J Orthop 511 




30. Graceffa V, Vinatier C, Guicheux J, Stoddart M, Alini M, Zeugolis DI. Chasing chimeras – the 514 
elusive stable chondrogenic phenotype. Biomaterials 2019;192:199–225. 515 
https://doi.org/10.1016/j.biomaterials.2018.11.014 516 
  517 
31. Hall AC. The role of chondrocyte morphology and volume in controlling phenotype – 518 
implications for osteoarthritis, cartilage repair and cartilage engineering. Curr Top Rheumatol 519 
2019;21:38 https://doi: 10.1007/s11926-019-0837-6 520 
 521 
32. Holloway I, Kayser M, Lee DA, Bader DL, Bentley G, Knight MM. Increased presence of cells 522 
with multiple elongated processes in osteoarthritic femoral head cartilage. Osteoarthritis and 523 
Cartilage 2004;12:17–24. https://doi.org/10.1016/joca.2003.09.001. 524 
 525 
33. Tesche F, Miosge N. New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-526 
like chondrocytes in late stages of the disease. Histol Histopathol 2005;20:329–37. DOI: 527 
10.14670/HH-20.329 528 
 529 
34. Lotz MK, Otsuki S, Grogan SP, Sah R, Terkeltaub R, D’Lima D. Cartilage cell clusters. Arthritis 530 
Rheum 2010;62:2206–2218. DOI: 10.1002/art.27528. 531 
 532 
35. Nomura M, Sakitani N, Iwaawa H, Kohara Y, Takano S, Wakimoto Y, et al. Thinning of articular 533 
cartilage after joint unloading or immobilization. An experimental investigation of the pathogenesis 534 
in mice. Osteoarthritis and Cartilage 2017;25:727-736. DOI: 10.1002/jor.1100070305 535 
 536 
36. Loqman MY, Bush PG, Farquharson C, Hall AC. A cell shrinkage artefact in growth plate 537 
chondrocytes with common fixative solutions: importance of fixative osmolarity for maintaining 538 
morphology. Eur. Cell. Mater. 2010;19:214-27. DOI:10.22203/ecm.v019a21 539 
 540 
37. Grumbles RM, Howell DS, Howard GA, Roos BA, Setton LA, Mow VC, et al., Cartilage 541 




38. Palmoski M, Perricone E, Brandt KD. Development and reversal of a proteoglycan aggregation 544 
defect in normal canine knee cartilage after immobilization. Arth Rheum 1979;22:508–517. 545 
 546 
39. Behrens F, Kraft EL, Oegema TR Jr. Biochemical changes in articular cartilage after joint 547 
immobilization by casting or external fixation. J Orthop Res 1989;7(3):335-343. DOI: 548 
10.1002/jor.1100070305 549 
 550 
40. Sanchez-Adams J, Leddy HA, McNulty AL, O’Conor CJ, Guilak F. The mechanobiology of 551 
articular cartilage: bearing the burden of osteoarthritis.  Curr Rheumatol Rep 2014;16(10):451. 552 
DOI: 10.1007/s11926-014-0451-6. 553 
 554 
41. Wuest SL, Calio M, Wernas T, Tanner S, Giger-lange C, Wyss F, et al.  Influence of 555 
mechanical unloading on articular chondrocyte dedifferentiation. Int J Molecular Sciences 556 
2018;19(5). DOI: 10.3390/ijms19051289 557 
 558 
42. O’Conor CJ, Leddy HA, Benefield HC, Liedtke WB & Guilak F. TRPV4-mediated 559 
mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading. Proc 560 
Natl Acad Sci USA 2014;111:1316-1321. DOI: 10.1073/pnas.1319569111 561 
 562 
43. Lattouf R, Younes R, Lutomski D, Naaman N, Godeau, G., Senni, K, et al. Picrosirius red 563 
staining: A useful tool to appraise collagen networks in normal and pathological tissues. J 564 
Histochem Cytochem 2014;62(10):751–758. DOI: 10.1369/0022155414545787 565 
 566 
44. Haapala J, Arokoski JP, Hyttinen MM, Lammi M, Tammi M, Kovanen V, et al. Remobilization 567 





45. Aldahmash AM, El Fouhil AF, Mohamed RA, Ahmed AM, Atteya M, Al Sharawy SA, et al. 571 
Collagen types I and II distribution: a relevant indicator for the functional properties of articular 572 
cartilage in immobilised and remobilised rabbit knee joints. Folia Morphol 2015;74(2):169–175. 573 
DOI: 10.5603/FM.2015.0027. 574 
 575 
46. Heinemeier KM, Schjerling P, Heinemeier J, Møller MB, Krogsgaard MR, Grum-Schwensen T, 576 
et al.  Radiocarbon dating reveals minimal collagen turnover in both healthy and osteoarthritic 577 
human cartilage. Sci Transl Med 2016;8:346ra90.  DOI: 10.1126/scitranslmed.aad8335. 578 
 579 
47. Bush PG, Hall AC. Regulatory volume decrease (RVD) by isolated and in situ bovine articular 580 
chondrocytes. J Cell Physiol 2001;187:304-14. DOI: 10.1002/jcp.1077 581 
 582 
48. Lewis R, Feetham C, Barrett-Jolley R. Cell volume control in chondrocytes. Cell Physiol 583 
Biochem 2011;28:1111–22. DOI: 10.1159/000335847. 584 
 585 
49. Wang Z, Irianto J, Kazun S, Wang W, Knight MM. The rate of hypo-osmotic challenge 586 
influences regulatory volume decrease (RVD) and mechanical properties of articular chondrocytes. 587 
Osteoarthritis and Cartilage 2015;23:289-299. http://dx.doi.org/10.1016/j.joca.2014.11.003 588 
 589 
50. Gratal P, Mediero A, Sánchez-Pernaute O, Prieto-Potin I, Lamuedra A, Herrero-Beaumont, G, 590 
et al.  Chondrocyte enlargement is a marker of osteoarthritis severity. Osteoarthritis and Cartilage 591 
2019;27(8);1229-1234. DOI: 10.1016/j.joca.2019.04.013. 592 
 593 




Figure Legends. 596 
 597 
Figure 1. The cavity produced in the cancellous bone of the human femoral head to accommodate 598 
the magnetic bar for stirring culture experiments.   599 
 600 
Figure 2. Localisation of the cartilage area on human femoral heads used for sampling. (A) 601 
Lateral view of the femoral head, fovea (F) on the upper left, (B) Top view of the femoral head, (C) 602 
Femoral head with biopsy explants taken from within the specified zone. Scale bar represents 25mm. 603 
 604 
Figure 3. The viability of in situ human chondrocytes within femoral head cartilage cultured 605 
under various conditions. (A)  DMEM N(n)=4(16); DMEM + mixing (N(n)=3(12)). (B) DMEM + 606 
normal human serum (HS); (N(n)=3(12)), DMEM + mixing + human serum (N(n)=2(8)); error bars 607 
represent S.E.M. (or S.D. for N=2). (C) Representative images of viability staining (CMFDA green – 608 
live cells, PI red – dead cells) at week 10 for DMEM, DMEM + 10% human serum and DMEM + 609 
mixing; scale bars represent 100µm. 610 
 611 
Figure 4. Viability of chondrocytes in various zones after 10 weeks of femoral head culture 612 
(A) Comparison of chondrocyte viability in the whole thickness vs superficial zone at week 10 of 613 
culture. DMEM N(n)=4(16), *p=0.0425, DMEM + mixing, N(n)=3(12), *p=0.016 (data shown as mean 614 
± S.E.M.). (B) Representative coronal images of labelled chondrocytes within cartilage sections 615 
cultured in DMEM on day 0 (left panel), and after 10 weeks of culture in DMEM + mixing + HS on 616 
week 10 (right panel). The scale bars represent 100µm. 617 
 618 
Figure 5. Changes to the morphology of in situ femoral head chondrocytes during culture. 619 
Panel (A) shows the % of cells with cytoplasmic processes at three time points (weeks 0, 6 and 10) 620 
in cultures with DMEM (N(n) = 4(16)) and DMEM + human normal human serum (HS) (N(n) = 3(12)). 621 
(Data shown as mean ± S.D.).  Panel (B) shows representative images of cell stained with CMFDA 622 
25 
 
cell tracker green to visualise chondrocyte morphology, and propidium iodide (PI) red to identify dead 623 
cells. The top row of images is from DMEM cultures, (left to right panels for weeks 0, 6 and 10 624 
respectively), the bottom row of images for DMEM + human serum (left to right panels for weeks 0, 625 
6 and 10 respectively. Note examples of chondrocytes with cellular processes indicated by white 626 
arrowheads. The scale bar represents 100µm. 627 
 628 
Figure 6. Histology of femoral head cartilage with time in culture.  (A) GAG content in various 629 
culture conditions, (a) DMEM N(n)=4(8), (b) DMEM + mixing N(n)=4(8), (c) DMEM + 10% human 630 
serum N(n)=3(6), *p=0.028. (B) Cartilage thickness in various culture conditions, (a) DMEM 631 
N(n)=4(24), (b) DMEM + mixing N(n)=4(24), (c) DMEM + 10% human serum N(n)=3(18), (p=0.05; 632 
p=0.02; p=0.02 respectively). (Data shown as mean ± S.E.M.).  (C) Representative images for Alcian 633 
blue staining of DMEM + human serum on week 0 (left panel) and week 10 (right panel). 634 
 635 
Figure 7. Surface roughness, chondrocyte density and volume of in situ femoral head 636 
chondrocytes with time in culture in DMEM + HS. (A) Surface roughness expressed as the root 637 
mean square (RMS) deviation)) in µm at week 0 and week 10, N(n)=3(9), p=0.2). (B) Cell density 638 
(total number of chondrocytes per mm3) at week 0 and week 10, N(n)=3(60), p=0.22. (C) 639 
Chondrocyte volume at week 0 and week 10, N(n)=3(44), p=0.22. Broken lines illustrate pairs of data 640 
at week 0 and week 10 for each femoral head. (Data shown as mean ± S.D.).   641 
 642 
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